Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy
Lauren A. Eberly(University of Pennsylvania), Neal K. Lakdawala(Brigham and Women's Hospital), Christine E. Seidman(Harvard University), John L. Jefferies(St. Luke's Episcopal Hospital), Christopher Semsarian(The University of Sydney), Larry Han(Brigham and Women's Hospital), Iacopo Olivotto(Azienda Ospedaliero-Universitaria Careggi), Joseph W. Rossano(Children's Hospital of Philadelphia), Alexandre C. Pereira(University of Washington), Nadine Channaoui(Brigham and Women's Hospital), Daniel Jacoby(Baim Institute for Clinical Research), Jodie Ingles, Euan A. Ashley(Stanford University), Allison L. Cirino(University of Campania "Luigi Vanvitelli"), Steven D. Colan(Boston Children's Hospital), Sharlene M. Day(University of Pennsylvania), Carolyn Y. Ho(Brigham and Women's Hospital)
Cited by 109
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k